MYmAb Biologics Recognised as VIP at Healthcare+ Expo Taiwan, Strengthening Its Global Healthcare Presence
MYmAb Biologics is a trusted tissue microarray company (https://www.mymab.com.my/) providing high-quality human tissue microarrays (TMAs) for both clinical and research applications. With a strong commitment to ethical sourcing, rigorous quality standards, and reliable global distribution, MYmAb Biologics supports researchers worldwide in advancing translational research and oncology studies using clinically relevant human tissue samples.
Last week, MYmAb Biologics was honoured to be invited as a VIP guest at the Healthcare+ Expo Taiwan, held at the Taipei Nangang Exhibition Center. The invitation reflects MYmAb Biologics’ growing recognition within the international healthcare and biotechnology ecosystem, as well as its role in supporting globally relevant research solutions.
The Healthcare+ Expo Taiwan is an annual flagship event that brings together innovative technologies, emerging healthcare solutions, and industry leaders from across the world. The event provided an eye-opening platform for MYmAb Biologics to engage with participants from diverse regions and gain insights into cutting-edge advancements shaping the future of healthcare and biotechnology.
In conjunction with the exhibition, MYmAb Biologics also participated in Healthcare+ B2B, a global business-matching platform that connects buyers and suppliers year-round. This participation opened opportunities for meaningful discussions, potential collaborations, and long-term partnerships beyond the physical exhibition, further strengthening MYmAb Biologics’ international network.
MYmAb Biologics extends a special thank you to Bioeconomy Corporation for the kind invitation and excellent arrangements, which contributed to a highly productive and valuable experience.
The company looks forward to applying the insights gained from Healthcare+ Expo Taiwan and continuing to contribute to meaningful advancements in the healthcare and biotechnology sectors through its tissue microarray solutions.
To learn more about MYmAb Biologics and its tissue microarray offerings, visit the MYmAb Biologics website.
This news article is provided and written by Pillars Media (https://pillarsmedia.my/).